| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Reactivity of Langerhans cells with hybridoma antibody.
|
Proc Natl Acad Sci U S A
|
1981
|
3.62
|
|
2
|
Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders.
|
Ann Intern Med
|
1975
|
3.36
|
|
3
|
Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results.
|
N Engl J Med
|
1987
|
3.13
|
|
4
|
Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy.
|
J Am Acad Dermatol
|
1992
|
1.75
|
|
5
|
Successful management of the Sézary syndrome. Mobilization and removal of extravascular neoplastic T cells by leukapheresis.
|
N Engl J Med
|
1974
|
1.35
|
|
6
|
Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes.
|
J Invest Dermatol
|
1989
|
1.21
|
|
7
|
Selective killing of T lymphocytes by phototoxic liposomes.
|
Proc Natl Acad Sci U S A
|
1987
|
1.13
|
|
8
|
Migration inhibitory activity in serum and cell supernatants in patients with Sezary syndrome.
|
J Immunol
|
1975
|
1.07
|
|
9
|
Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes.
|
J Invest Dermatol
|
1990
|
1.04
|
|
10
|
A human leukemia cell with both B and T cell surface receptors.
|
Proc Natl Acad Sci U S A
|
1974
|
0.98
|
|
11
|
Reversible resistance to apoptosis in cutaneous T cell lymphoma.
|
Ann N Y Acad Sci
|
2001
|
0.89
|
|
12
|
In situ study of T-cell subpopulations in cutaneous T-cell lymphoma. Diagnostic criteria.
|
Cancer
|
1984
|
0.86
|
|
13
|
Patterns of cell proliferation and cell migration in the Sézary syndrome.
|
Blood
|
1981
|
0.85
|
|
14
|
Kaposi's sarcoma following chemotherapy for testicular cancer in a homosexual man: demonstration of cytomegalovirus RNA in sarcoma cells.
|
Hum Pathol
|
1982
|
0.84
|
|
15
|
Chest-wall deformity following soft-tissue expansion for breast reconstruction.
|
Plast Reconstr Surg
|
1987
|
0.83
|
|
16
|
The kinetics of Sézary cell production.
|
Cancer Treat Rep
|
1979
|
0.83
|
|
17
|
Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience.
|
Yale J Biol Med
|
1990
|
0.82
|
|
18
|
Cytogenetic studies and clinical implications in patients with Sézary syndrome.
|
Cancer
|
1976
|
0.82
|
|
19
|
Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma.
|
Arch Dermatol
|
1994
|
0.81
|
|
20
|
Correlations of unique clinical, immunotypic, and histologic findings in cutaneous gamma/delta T-cell lymphoma.
|
J Am Acad Dermatol
|
1992
|
0.80
|
|
21
|
Endocytosis of the TCR/CD3 complex and the class-I major histocompatibility complex in a human T cell line.
|
Cell Immunol
|
1991
|
0.80
|
|
22
|
Thymopoietin-like substance in human skin.
|
Lancet
|
1982
|
0.79
|
|
23
|
Reactivity of lupus erythematosus antibodies with leukemic helper T cells.
|
J Invest Dermatol
|
1978
|
0.79
|
|
24
|
Immunology of cutaneous T-cell lymphoma.
|
J Natl Cancer Inst
|
1991
|
0.79
|
|
25
|
The delivery of phototoxic drugs to selected cells.
|
Ann N Y Acad Sci
|
1985
|
0.78
|
|
26
|
Cutaneous T-cell lymphoma.
|
Cancer
|
1976
|
0.77
|
|
27
|
Literature as an introduction to psychiatric ethics.
|
Acad Psychiatry
|
1998
|
0.77
|
|
28
|
Relaxation measured by EMG as a function of vibrotactile stimulation.
|
Biofeedback Self Regul
|
1976
|
0.76
|
|
29
|
Molecular cloning of CD1a (T6), a human epidermal dendritic cell marker related to class I MHC molecules.
|
J Invest Dermatol
|
1989
|
0.76
|
|
30
|
Concanvalin-A-binding proteins on the surface of human malignant and normal lymphocytes.
|
Scand J Immunol
|
1979
|
0.76
|
|
31
|
The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma.
|
Ann N Y Acad Sci
|
2001
|
0.76
|
|
32
|
Regulation of transgenic class II major histocompatibility genes in murine Langerhans cells.
|
J Invest Dermatol
|
1995
|
0.76
|
|
33
|
Anticoagulation. II. Anticoagulant usage in cerebrovascular disease.
|
Med Ann Dist Columbia
|
1974
|
0.75
|
|
34
|
Effect of prednisolone and cyclophosphamide on inhibition of the response to alloantigen induced by treatment with photoinactivated effector T cells (PET cells).
|
Ann N Y Acad Sci
|
1991
|
0.75
|
|
35
|
Monoclonal antibodies: powerful new tools for the clinician.
|
Arch Dermatol
|
1982
|
0.75
|
|
36
|
Reactivity of monoclonal antibody BE 2 in different stages of mycosis fungoides and in benign dermal infiltrates.
|
Arch Dermatol Res
|
1986
|
0.75
|
|
37
|
Extracorporeal photochemotherapy: indications, methodology, safety aspects, side effects and long-term results.
|
Photodermatol
|
1989
|
0.75
|
|
38
|
Induction of an immature T-cell phenotype in malignant helper T cells by cocultivation with epidermal cell cultures.
|
J Invest Dermatol
|
1987
|
0.75
|
|
39
|
Nonmelanoma skin cancer, melanomas, warts, and viral oncogenesis.
|
J Am Acad Dermatol
|
1984
|
0.75
|
|
40
|
The skin and T-cell differentiation.
|
N Engl J Med
|
1980
|
0.75
|
|
41
|
Locomotion of T cells from patients with cutaneous T-cell lymphoma (Sézary syndrome and mycosis fungoides).
|
Cell Immunol
|
1980
|
0.75
|
|
42
|
Repair of 8-MOP photoadducts in human lymphocytes.
|
Basic Life Sci
|
1990
|
0.75
|
|
43
|
Phototoxic liposomes coupled to an antibody that alone cannot modulate its cell-surface antigen kill selected target cells.
|
Cancer Immunol Immunother
|
1990
|
0.75
|